As of November 6, 2026, BriaCell Therapeutics Corp. is a publicly traded company (Nasdaq: BCTX). Plambeck Jeremy Myung Jae reports holding 100%, a majority of its shares. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Kenneth Griffin (9.99%), Richard Abbe (9.1%) (Schedule 13G, October 10, 2025).
Is this your company?
About to sign with, pay or invest in BriaCell Therapeutics Corp.? See the free Snapshot first.
Free to see. No signup.
Is BriaCell Therapeutics Corp. a real, registered company?
- BriaCell Therapeutics Corp. files with the SEC under CIK 1610820 (its SEC filings).
- Its shares are listed under the ticker BCTX on Nasdaq (also BCTXL, BCTXZ) (SEC company record).
- Incorporated in A1; business address in West Vancouver, A1, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BriaCell Therapeutics Corp. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Kenneth Griffin (filed 2026-01-23).
Who are BriaCell Therapeutics Corp.'s owners and officers?
BriaCell Therapeutics Corp.: business address in West Vancouver, A1; industry Pharmaceutical Preparations (Schedule 13G, 2026-01-23).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-01-23 | Kenneth Griffin | 9.99% |
| Schedule 13G/A, 2025-11-07 | Cvi Investments, Inc. | 4.9% |
| Schedule 13G, 2025-10-10 | Plambeck Jeremy Myung Jae | 100% |
| Schedule 13G, 2025-07-28 | Richard Abbe | 9.1% |
| Schedule 13G, 2025-07-22 | Cvi Investments, Inc. | 5.7% |
| Schedule 13G/A, 2025-07-21 | Cvi Investments, Inc. | 4.9% |
Questions about who owns BriaCell Therapeutics Corp.
Who owns BriaCell Therapeutics Corp.?
On this page, 3 holders' latest ownership filings report 5% or more of BriaCell Therapeutics Corp.: Plambeck Jeremy Myung Jae (100%, Schedule 13G, filed 2025-10-10), Kenneth Griffin (9.99%, Schedule 13G, filed 2026-01-23) and Richard Abbe (9.1%, Schedule 13G, filed 2025-07-28).
Who are the largest shareholders of BriaCell Therapeutics Corp.?
By the share each holder's latest filing reports, the largest holders of BriaCell Therapeutics Corp. on this page are Plambeck Jeremy Myung Jae (100%), Kenneth Griffin (9.99%) and Richard Abbe (9.1%).
When did Plambeck Jeremy Myung Jae buy into BriaCell Therapeutics Corp.?
The filings give report dates, not purchase dates. The earliest filing from Plambeck Jeremy Myung Jae on this page is the Schedule 13G, filed 2025-10-10, reporting 100%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on BriaCell Therapeutics Corp.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BriaCell Therapeutics Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BriaCell Therapeutics Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has BriaCell Therapeutics Corp. raised?
Latest IPO step: BriaCell Therapeutics Corp. filed its final IPO prospectus, ticker BCTXL (424B4, 2026-01-14).
IPO filings: 424B4, 2026-01-14, S-1, 2025-12-23, 424B4, 2025-07-16, S-1/A, 2025-07-10, S-1/A, 2025-07-09; ticker BCTXL on Nasdaq.
Keep reading
More on BriaCell Therapeutics Corp. and the records around it.
BriaCell Therapeutics Corp. elsewhere on the record
- 5%+ stake filings Jan 2026
- IPO filing Jan 2026
Companies that share a holder
- Iroquois Capital Management, LLC also filed stake reports on 13 other companies: 22nd Century Group (Aug 2026), XWELL, Inc. (Aug 2026), Clearmind Medicine Inc. (Aug 2026)
- CVI Investments, Inc. also filed stake reports on 48 other companies: Pine Tree Acquisition Corp. (Oct 2026), Sunshine Biopharma Inc. (Oct 2026), Outlook Therapeutics, Inc. (Aug 2026)
- Citadel Advisors LLC also filed stake reports on 58 other companies: Quantinuum Inc. (Oct 2026), REALLOYS INC. (Oct 2026), STARFIGHTERS SPACE, INC. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/briacell-therapeutics